Development and Validation of a Large Language Model-based Myopia Assistant System
1 other identifier
interventional
70
1 country
1
Brief Summary
Myopia is a rapidly growing global health concern, and there is an urgent need for advanced tools that can facilitate personalized healthcare strategies. Artificial intelligence (AI)-based solutions, such as large language models, offer robust tools for ophthalmic healthcare. In this study, investigators aim to validate a patient-centered Large Language Model (LLM)-based Myopia Assistant System with the following key objectives: 1) evaluate the ability of the LLM models to generate high-level reports and help self-evaluation of myopia for patients in primary care; 2) evaluate its performance in answering evidence-based medicine-oriented questions and improving overall satisfaction within clinics for myopic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2024
CompletedStudy Start
First participant enrolled
September 21, 2024
CompletedFirst Posted
Study publicly available on registry
September 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 26, 2024
CompletedMarch 13, 2025
February 1, 2025
1 month
September 11, 2024
March 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Satisfaction level
Participants satisfaction level of the clinical experience with or without the use of a patient-centered assistant system based on a large language model (LLM) was assessed. The total satisfaction score was reported using the questionnaire (Patient User Satisfaction Scale), which evaluated the participant satisfaction with the clinical experience and the effectiveness of resolving their own issues. The questionnaire was measured on a 5-point Likert scale, where 1 represents strongly disagree; and 5 represents strongly agree; with higher scores indicating greater satisfaction.
Immediately after the outpatient clinic visit procedure
Secondary Outcomes (1)
Whether participants adopt the myopia management advice from the physician
Immediately after the outpatient clinic visit procedure
Study Arms (2)
Patient-centered assistant system
EXPERIMENTALParticipants engaged in the outpatient clinic visit procedure with a patient-centered assistant system based on Large-Language Model (LLM) for 10 minutes.
Control group
NO INTERVENTIONParticipants engaged in the outpatient clinic visit procedure without the support of patient-centered assistant system based on Large-Language Model (LLM) or any similar artificial intelligence assistance for 10 minutes.
Interventions
Participants will engage in a 10-minute medical consultation using LLM model interface embedded in a tablet device before their regular face-to-face consulation with physicians. During the trials, participants could engage in free conversations covering aspects including risk factors, symptoms, diagnosis, examinations, treatment, advice and caution, etc. Participants who have completed the ophthalmic imaging examination will be asked to input results into the assistant model to generate structured reports.
Eligibility Criteria
You may qualify if:
- Outpatient participants aged 6 to 75.
- Participants who undergo ophthalmic examinations for medical purposes.
- Participants who can produce clear ophthalmic images in both eyes.
- No prior experience in research involving digital medicine
- Agree to participate in this study with written informed consent
You may not qualify if:
- Participants who are reluctant to participate in this study
- Participants who are unable to understand the study.
- Participants who have recently undergone ocular surgery or those with severe ocular conditions that may affect the interpretation of imaging results related to myopia evaluation (e.g., severe vitreous hemorrhage, cataracts, corneal leukoma, etc.) will be excluded from the study.
- Participants with poor quality of ophthalmic images, including blurriness, artifacts, underexposure, or overexposure.
- Other unsuitable reasons determined by the evaluators.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hong Kong Polytechnic University
Hong Kong, Hong Kong, 000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mingguang He, M.D, Ph.D
The Hong Kong Polytechnic University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2024
First Posted
September 23, 2024
Study Start
September 21, 2024
Primary Completion
October 26, 2024
Study Completion
October 26, 2024
Last Updated
March 13, 2025
Record last verified: 2025-02